Literature DB >> 25346567

A Comparison of Cognitive and Everyday Functional Performance among Older Adults With and Without Hypertension.

Elizabeth M Hudak1, Jerri D Edwards1, Ponrathi Athilingam1, Cathy L McEvoy1.   

Abstract

Secondary data analyses examined the differences in cognitive and instrumental activities of daily living (IADL) performance among hypertensive individuals taking one of four classes of antihypertensive medications, hypertensive individuals not taking any antihypertensive medications, and normotensive individuals (N=770). After adjusting for covariates, significant group differences were evident on all measures (speed of processing, motor speed, reaction time, ps < .05) except memory and Timed IADL (ps > .05). Follow-up a priori planned comparisons compared hypertensive individuals not on medications to each of the four antihypertensive medication groups. Results indicated that only those on beta blockers (BB) were significantly slower in speed of processing (ps < .05). A priori planned comparisons also revealed that normotensive individuals had better cognitive performance on measures of processing speed, motor speed, and reaction time than hypertensive individuals regardless of antihypertensive medication use. Additionally, normotensive individuals performed significantly better on memory (Digit and Spatial Span) than individuals with hypertension on medications. No differences were found between groups on memory (Hopkins Verbal Learning Test) or Timed IADL performance. With regard to antihypertensive medications, the use of BBs was associated with slowed processing speed. These analyses provide empirical evidence that hypertension primarily impacts speed of processing, but not severe enough to affect IADL performance. Given the contribution of processing speed to memory and executive function performance, this is an important finding. Clinicians need to take into consideration the potential negative impact that BBs may have on cognition when determining the best treatment of hypertension among older adult patients.

Entities:  

Keywords:  Hypertension; antihypertensive medications; instrumental activities of daily living; older adults; speed of processing

Year:  2013        PMID: 25346567      PMCID: PMC4208459          DOI: 10.1080/07317115.2012.749322

Source DB:  PubMed          Journal:  Clin Gerontol        ISSN: 0731-7115            Impact factor:   2.619


  39 in total

1.  Cognitive predictors of everyday functioning in older adults: results from the ACTIVE Cognitive Intervention Trial.

Authors:  Alden L Gross; George W Rebok; Frederick W Unverzagt; Sherry L Willis; Jason Brandt
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-05-09       Impact factor: 4.077

2.  Prevalence of hypertension and controlled hypertension - United States, 2005-2008.

Authors:  Nora L Keenan; Kimberly A Rosendorf
Journal:  MMWR Suppl       Date:  2011-01-14

3.  Cognitive impairment as a strong predictor of incident disability in specific ADL-IADL tasks among community-dwelling elders: the Azuchi Study.

Authors:  Hiroko H Dodge; Takashi Kadowaki; Takehito Hayakawa; Masanobu Yamakawa; Akira Sekikawa; Hirotugu Ueshima
Journal:  Gerontologist       Date:  2005-04

4.  Predictors of functional change: a longitudinal study of nondemented people aged 65 and older.

Authors:  Li Wang; Gerald van Belle; Walter B Kukull; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2002-09       Impact factor: 5.562

5.  Aging and Executive Control: Reports of a Demise Greatly Exaggerated.

Authors:  Paul Verhaeghen
Journal:  Curr Dir Psychol Sci       Date:  2011-06

6.  Effects of cognitive training interventions with older adults: a randomized controlled trial.

Authors:  Karlene Ball; Daniel B Berch; Karin F Helmers; Jared B Jobe; Mary D Leveck; Michael Marsiske; John N Morris; George W Rebok; David M Smith; Sharon L Tennstedt; Frederick W Unverzagt; Sherry L Willis
Journal:  JAMA       Date:  2002-11-13       Impact factor: 56.272

7.  Effects of six anti-hypertensive medications on cognitive performance.

Authors:  Matthew F Muldoon; Shari R Waldstein; Christopher M Ryan; John Richard Jennings; Joanna M Polefrone; Alvin P Shapiro; Stephen B Manuck
Journal:  J Hypertens       Date:  2002-08       Impact factor: 4.844

8.  Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial.

Authors:  B K Saxby; F Harrington; K A Wesnes; I G McKeith; G A Ford
Journal:  Neurology       Date:  2008-05-06       Impact factor: 9.910

Review 9.  Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?

Authors:  Hean Teik Ong
Journal:  J Am Board Fam Med       Date:  2009 Nov-Dec       Impact factor: 2.657

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

View more
  3 in total

1.  Interactive effects of subjective memory complaints and hypertension on learning and memory performance in the elderly.

Authors:  Lauren A Nguyen; Kari A Haws; Megan C Fitzhugh; Gabrielle A Torre; Georg A Hishaw; Gene E Alexander
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2015-07-17

2.  Independent and Differential Effects of Obesity and Hypertension on Cognitive and Functional Abilities.

Authors:  Robert P Fellows; Maureen Schmitter-Edgecombe
Journal:  Arch Clin Neuropsychol       Date:  2018-02-01       Impact factor: 2.813

3.  Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.

Authors:  Jean K Ho; Frank Moriarty; Jennifer J Manly; Eric B Larson; Denis A Evans; Kumar B Rajan; Elizabeth M Hudak; Lamiaa Hassan; Enwu Liu; Nobuyuki Sato; Naoyuki Hasebe; Danielle Laurin; Pierre-Hugues Carmichael; Daniel A Nation
Journal:  Hypertension       Date:  2021-06-21       Impact factor: 9.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.